ARTICLE | Clinical News
Evolocumab: Phase III data
January 27, 2014 8:00 AM UTC
Top-line data from the double-blind, placebo- and active-controlled, international Phase III GAUSS-2 in 307 statin-intolerant patients with hyperlipidemia showed that subcutaneous evolocumab met the c...